Anodic oxidation of 5-aminouracil

Patent metadata

Field	Value
Publication number	US-11708336-B2
Application number	US-202017066702-A
Country	US
Kind code	B2
Filing date	Oct 9, 2020
Priority date	Oct 10, 2019
Publication date	Jul 25, 2023
Grant date	Jul 25, 2023

Abstract

A process for preparing pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is provided. A process for the preparation of 3,6-diaminopyrazine-2,5-dicarboxylic acid, or a salt thereof, from pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, or a salt thereof, is further provided. A process for preparing a substituted pteridine compound, or a salt thereof, is further provided. A process for the preparation of a N-substituted 3,6-diaminopyrazine-2,5-dicarboxylic acid from a substituted pteridine compound, or a salt thereof, is further provided.

First claim

What is claimed is:

1. A process for preparing divalent salts of pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, Compound 2, the process comprising step 1a directed to anodic oxidation of 5-aminopyrimidine-2,4(1H,3H)-dione, Compound 1, in the presence of an aqueous base to form pyrimido[4,5-g]pteridine-2,4,7,9-tetraol, Compound 2a, followed by step 1b directed to treatment of compound 2a with a base to form Compound 2 as follows:

wherein A + is a monovalent cation.

2. The process of claim 1 , wherein the base in step 1b is KOH and compound 2 is potassium 4,9-dihydroxypyrimido[4,5-g]pteridine-2,7-bis(olate) of the structure:

3. The process of claim 1 , wherein steps 1a and 1b are done in an electrochemical cell.

4. The process of claim 3 , wherein the electrochemical cell comprises divided cells.

5. The process of claim 3 , wherein the electrochemical cell comprises undivided cells.

6. The process of claim 1 , further comprising hydrolyzing Compound 2, in the presence of a base to form 3,6-diaminopyrazine-2,5-dicarboxylic acid, Compound 3, as follows:

7. The process of claim 6 , further comprising reacting 3,6-diaminopyrazine-2,5-dicarboxylic acid with an acid salt of NHR, Compound 4, to form Compound 5, as follows:

wherein each NHR is independently
(i) a polypeptide chain that includes one or more natural or unnatural α-amino acids linked together by peptide bonds, or
(ii) NH(R 1 )(R 2 ) wherein:
each R 1 is independently —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 10 CONR 11 (CH 2 ) d (CH 2 CH 2 O) e R 20 , —(CH 2 ) a (CH 2 CH 2 O) b (CH2) c NR 12 CSNR 13 (CH 2 ) d (CH 2 CH 2 O) e R 21 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c CONR 14 (CH 2 ) a (CH 2 CH 2 O) e R 22 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 15 SO 2 (CH 2 ) a (CH 2 CH 2 O) e R 23 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c SO 2 NR 16 (CH 2 ) a (CH 2 CH 2 O) e R 24 , —(CH2) a (CH 2 CH 2 O) b (CH 2 ) c NR 17 CO(CH 2 ) a (CH 2 CH 2 O) e R 25 , —(CH2) a (CH 2 CH 2 O) b (CH 2 ) c NR 18 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 26 , or —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c OC(O)NR 19 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 27 ; —(CH 2 ) c OR 68 , —CH 2 (CHOH) c R 69 , —CH 2 (CHOH) c CO 2 H, —(CHCO 2 H) c CO 2 H, —(CH 2 ) c NR 70 R 71 , —CH[(CH 2 ) f NH 2 ] c CO 2 H, —CH[(CH 2 ) f NH 2 ] c CH 2 OH, —CH 2 (CHNH 2 ) c CH2NR 72 R 73 , —(CH 2 CH 2 O) e R 74 , —(CH 2 ) t CO(CH 2 CH 2 O) e R 75 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 58 C(O)NR 59 (CH 2 ) l (CH 2 CH 2 O) o R 76 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 60 C(S)NR 61 (CH 2 ) l (CH 2 CH 2 O) o R 77 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k C(O)NR 62 (CH 2 ) l (CH 2 CH 2 O) o R 78 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k S(O) 2 NR 63 (CH 2 ) l (CH 2 CH 2 O) o R 79 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 64 S(O) 2 (CH 2 ) l (CH 2 CH 2 O) o R 80 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 65 C(O)(CH 2 ) l (CH 2 CH 2 O) o R 81 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 66 C(O)O(CH 2 ) l (CH 2 CH 2 O) o R 82 , or —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k OC(O)NR 67 (CH 2 ) l (CH 2 CH 2 O) o R 83 , —(CH 2 ) a SO 3 H, —(CH 2 ) a SO 3 − , —(CH 2 ) a OSO 3 H, —(CH 2 ) a OSO 3 − , —(CH 2 ) a NHSO 3 H, —(CH 2 ) a NHSO 3 − , —(CH 2 ) a PO 3 H 2 , —(CH 2 ) a PO 3 H − , —(CH 2 ) a PO 3 = , —(CH 2 ) a OPO 3 H 2 , —(CH 2 ) a OPO 3 H − , or —(CH 2 ) a OPO 3 ;
each of R 2 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 58 , R 59 , R 60 , R 61 , R 62 , R 63 , R 64 , R 65 , R 66 and R 67 is independently —H or —CH 3 ;
each of R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 is independently —H, —CH 3 , —(CH 2 ) f NR 28 C(O)NR 29 (CH 2 ) g (CH 2 CH 2 O) h R 38 , —(CH 2 ) f NR 30 CSNR 31 (CH 2 ) g (CH 2 CH 2 O) h R 39 , —(CH 2 ) f C(O)NR 32 (CH 2 ) g (CH 2 CH 2 O) h R 40 , —(CH 2 ) f S(O) 2 NR 33 (CH 2 ) g (CH 2 CH 2 O) h R 41 , —(CH 2 ) f NR 34 S(O) 2 (CH 2 ) g (CH 2 CH 2 O) h R 42 , —(CH 2 ) f NR 35 C(O)(CH 2 ) g (CH 2 CH 2 O) h R 43 , —(CH 2 ) f NR 36 C(O)O(CH 2 ) g (CH 2 CH 2 O) h R 44 , —(CH 2 ) f OC(O)NR 37 (CH 2 ) g (CH 2 CH 2 O) h R 45 , —CO(AA), or —CONH(PS);
each of R 28 , R 29 , R 30 , R 31 , R 32 , R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , R 41 , R 42 , R 43 , R 44 , R 45 , R 46 , R 47 and R 48 is independently —H or —CH 3 ; each of R 68 , R 69 , R 70 , R 71 , R 72 , R 73 , R 74 , R 75 , R 76 , R 77 , R 78 , R 79 , and R 80 is independently —H, —CH 3 , —(CH 2 ) p S(O) 2 NR 84 (CH 2 ) q (CH 2 CH 2 O) s R 81 , —(CH 2 ) p NR 85 S(O) 2 (CH 2 ) q (CH 2 CH 2 O) s R 83 , —(CH 2 ) p NR 86 C(O)(CH 2 ) q (CH 2 CH 2 O) s R 85 , —(CH 2 ) p NR 86 C(O)O(CH 2 ) q (CH 2 CH 2 O) s R 87 , or —(CH 2 ) p OC(O)NR 88 (CH 2 ) q (CH 2 CH 2 O) s R 89 ;
each of R 81 , R 82 , R 83 , R 84 , R 85 , R 86 , R 87 , R 88 , and R 89 is independently —H or —CH 3 ;
each (AA) is independently a polypeptide chain that includes one or more natural or unnatural α-amino acids linked together by peptide bonds;
each (PS) is independently a sulfated or non-sulfated polysaccharide chain comprising one or more monosaccharide units connected by glycosidic linkages;
each of t and u is independently 1, 2, 3, 4, or 5;
each of a, d, g, 1, and q is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;
each of c, f, k, and p is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; and
each of b, j, e, h, o, and s is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100,
wherein each NHR moiety optionally comprises a protecting group.

8. The process of claim 7 , wherein NHR is D-serine comprising a benzyl protecting group.

9. The process of claim 7 , wherein each NHR moiety comprises a protecting group, PG, and wherein said protecting group is cleaved to form compound 6 as follows:

10. The process of claim 9 , wherein NHR is D-serine and compound 6 is (2R,2′R)-2,2′-((3,6-diaminopyrazine-2,5-dicarbonyl)bis(azanediyl))bis(3-hydroxypropanoic acid) of the following structure:

11. A process for preparing a substituted pteridine compound, the process comprising step 1a directed to anodic oxidation of compound 7, or a salt thereof, in the presence of a base and a solvent to form compound 8, or a salt thereof, as follows:

wherein R i and R ii are independently selected from: hydrogen, where only one of R i and R ii may be hydrogen; optionally substituted alkyl; optionally substituted ester; optionally substituted cycloalkyl or optionally substituted heterocycloalkyl; optionally substituted aryl or optionally substituted heteroaryl; optionally substituted alkoxy; optionally substituted —C(O)— alkyl; optionally substituted amino; optionally substituted polyol ethers and optionally substituted polyethers; a polypeptide chain (AA); and polysaccharide chain (

Assignees

• Medibeacon Inc

Inventors

• Rogers Thomas E

Classifications

• Y02P20/55

  Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title

• C25B3/09

  Nitrogen containing compounds · CPC title

• C25B3/07

  Oxygen containing compounds · CPC title

• C25B3/05

  Heterocyclic compounds · CPC title

• C25B3/23

  Oxidation (halogenation C25B3/27) · CPC title